TMDX - CIK 0001756262
TransMedics Group, Inc. (TMDX) reported net income of $190.30M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $190.30M | +436.1% |
| FY 2024 | $35.50M | +242.0% |
| FY 2023 | -$25.00M | +30.9% |
| FY 2022 | -$36.20M | +18.1% |
| FY 2021 | -$44.20M | -53.7% |
| FY 2020 | -$28.75M | +14.3% |
| FY 2019 | -$33.55M | -41.2% |
| FY 2018 | -$23.76M | - |
TransMedics Group, Inc. (TMDX) reported net income of $190.30M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2018 and fiscal 2025, TransMedics Group, Inc.'s net income grew from -$23.76M to $190.30M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.